Sanofi-Aventis to Acquire Genzyme for $20.1 Billion
06:57 AM | February 16, 2011 | Deepti Ramesh
Sanofi-Aventis says it has entered into a definitive agreement with biotechnology company Genzyme (Cambridge, MA), under which Sanofi-Aventis will acquire Genzyme for $74/share in cash, or about $20.1...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.